Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × daratumumab × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 117 Recurrence 9 Immunoglobulin Light-chain Amyloidosis 6 Neoplasms, Plasma Cell 5 Neoplasms 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myeloid, Acute 4 Smoldering Multiple Myeloma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm, Residual 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Hematologic Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmacytoma 2 Acute Kidney Injury 2 Triple Negative Breast Neoplasms 1 Proteostasis Deficiencies 1 Primary Myelofibrosis 1 Plasmablastic Lymphoma 1 Non-small Cell Lung Cancer With STK11/LKB1 Mutation 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1

Interventions

Rituximab 47 Cyclophosphamide 38 ibrutinib 22 fludarabine 22 acalabrutinib 20 venetoclax 18 Bendamustine Hydrochloride 18 zanubrutinib 15 Lenalidomide 15 CT-P10 13 fludarabine phosphate 12 Cytarabine 12 pirtobrutinib 11 obinutuzumab 11 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Etoposide 9 Vincristine 8 Doxorubicin 8 Biopsy 8 glofitamab 7 Whole-Body Irradiation 7 Mycophenolic Acid 6 Methotrexate 6 Melphalan 6 Peripheral Blood Stem Cell Transplantation 5 Immunotherapy, Adoptive 5 Cyclosporine 5 orelabrutinib 4 brexucabtagene autoleucel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡